Met Life Investment Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Met Life Investment Management, LLC

  • $20.1 Billion
  • Q3 2025

A detailed history of Met Life Investment Management, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 32,309 shares of VNDA stock, worth $140,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,309
Previous 32,860 1.68%
Holding current value
$140,544
Previous $155,000 3.87%
% of portfolio
0.0%
Previous 0.0%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$4.19 - $5.1 $2,308 - $2,810
-551 Reduced 1.68%
32,309 $161,000
Q2 2025

Aug 13, 2025
BUY
$3.92 - $4.82 $172 - $212
44 Added 0.13%
32,860 $155,000
Q1 2025

May 14, 2025
BUY
$4.31 - $5.13 $22,455 - $26,727
5,210 Added 18.87%
32,816 $150,000
Q4 2024

Feb 13, 2025
SELL
$4.41 - $5.46 $24,175 - $29,931
-5,482 Reduced 16.57%
27,606 $132,000
Q2 2024

Aug 13, 2024
BUY
$3.91 - $6.5 $12,996 - $21,606
3,324 Added 11.17%
33,088 $186,000
Q1 2024

May 14, 2024
BUY
$3.47 - $4.61 $103,281 - $137,212
29,764 New
29,764 $122,000
Q2 2023

Apr 29, 2024
BUY
$5.9 - $6.95 $180,545 - $212,676
30,601 New
30,601 $201,000
Q1 2023

May 09, 2024
BUY
$6.18 - $7.99 $189,114 - $244,501
30,601 New
30,601 $208 Million
Q1 2022

May 10, 2024
BUY
$10.84 - $16.55 $331,714 - $506,446
30,601 New
30,601 $346,000
Q1 2022

Mar 22, 2023
BUY
$10.84 - $16.55 $119,120 - $181,867
10,989 Added 56.03%
30,601 $346,000
Q1 2022

May 12, 2022
BUY
$10.84 - $16.55 $119,120 - $181,867
10,989 Added 56.03%
30,601 $346,000
Q4 2021

May 17, 2024
BUY
$15.69 - $21.14 $51,478 - $69,360
3,281 Added 20.09%
19,612 $307,000
Q4 2021

Jun 21, 2023
SELL
$15.69 - $21.14 $172,417 - $232,307
-10,989 Reduced 35.91%
19,612 $307,000
Q4 2021

Mar 22, 2023
BUY
$15.69 - $21.14 $51,478 - $69,360
3,281 Added 20.09%
19,612 $307,000
Q4 2021

Feb 15, 2022
BUY
$15.69 - $21.14 $51,478 - $69,360
3,281 Added 20.09%
19,612 $308,000
Q3 2021

May 17, 2024
SELL
$15.35 - $21.27 $77,563 - $107,477
-5,053 Reduced 23.63%
16,331 $279,000
Q3 2021

Jun 21, 2023
SELL
$15.35 - $21.27 $219,044 - $303,522
-14,270 Reduced 46.63%
16,331 $279,000
Q3 2021

Mar 22, 2023
SELL
$15.35 - $21.27 $77,563 - $107,477
-5,053 Reduced 23.63%
16,331 $279,000
Q3 2021

Nov 15, 2021
SELL
$15.35 - $21.27 $77,563 - $107,477
-5,053 Reduced 23.63%
16,331 $280,000
Q2 2021

Jun 21, 2023
SELL
$15.71 - $21.51 $144,799 - $198,257
-9,217 Reduced 30.12%
21,384 $459,000
Q1 2021

May 17, 2024
SELL
$13.42 - $20.28 $112,459 - $169,946
-8,380 Reduced 28.15%
21,384 $321,000
Q1 2021

Jun 26, 2023
SELL
$13.42 - $20.28 $123,692 - $186,920
-9,217 Reduced 30.12%
21,384 $321 Million
Q1 2021

Mar 22, 2023
SELL
$13.42 - $20.28 $39,615 - $59,866
-2,952 Reduced 12.13%
21,384 $321,000
Q1 2021

May 14, 2021
SELL
$13.42 - $20.28 $39,615 - $59,866
-2,952 Reduced 12.13%
21,384 $321,000
Q4 2020

Jun 22, 2023
SELL
$9.77 - $13.81 $61,209 - $86,519
-6,265 Reduced 20.47%
24,336 $319,000
Q3 2020

Jun 26, 2023
SELL
$9.32 - $12.02 $58,389 - $75,305
-6,265 Reduced 20.47%
24,336 $235,000
Q2 2020

May 24, 2024
SELL
$9.66 - $12.02 $52,434 - $65,244
-5,428 Reduced 18.24%
24,336 $278 Million
Q2 2020

Jun 26, 2023
SELL
$9.66 - $12.02 $60,519 - $75,305
-6,265 Reduced 20.47%
24,336 $278,000
Q1 2020

Jul 12, 2023
SELL
$7.5 - $16.8 $46,987 - $105,252
-6,265 Reduced 20.47%
24,336 $252,000
Q4 2019

Jul 12, 2023
SELL
$12.38 - $17.47 $77,560 - $109,449
-6,265 Reduced 20.47%
24,336 $399,000
Q3 2019

Jul 12, 2023
SELL
$12.27 - $15.79 $76,871 - $98,924
-6,265 Reduced 20.47%
24,336 $323,000
Q2 2019

Jul 12, 2023
SELL
$13.37 - $18.85 $83,763 - $118,095
-6,265 Reduced 20.47%
24,336 $342,000
Q1 2019

Jul 13, 2023
SELL
$17.59 - $31.05 $110,201 - $194,528
-6,265 Reduced 20.47%
24,336 $447,000
Q4 2018

Jul 13, 2023
SELL
$18.97 - $31.47 $118,847 - $197,159
-6,265 Reduced 20.47%
24,336 $635,000
Q4 2018

Mar 22, 2023
SELL
$18.97 - $31.47 $254,634 - $422,421
-13,423 Reduced 35.55%
24,336 $635,000
Q4 2018

Feb 14, 2019
SELL
$18.97 - $31.47 $254,634 - $422,421
-13,423 Reduced 35.55%
24,336 $636,000
Q3 2018

Jul 13, 2023
SELL
$18.25 - $23.0 $114,336 - $144,095
-6,265 Reduced 20.47%
24,336 $558,000
Q3 2018

Mar 22, 2023
BUY
$18.25 - $23.0 $130,633 - $164,634
7,158 Added 23.39%
37,759 $866,000
Q3 2018

Nov 14, 2018
BUY
$18.25 - $23.0 $244,969 - $308,729
13,423 Added 55.16%
37,759 $867,000
Q2 2018

Aug 15, 2018
BUY
$13.95 - $19.15 $56,678 - $77,806
4,063 Added 20.04%
24,336 $464,000
Q4 2017

Feb 15, 2018
BUY
$12.85 - $18.1 $260,508 - $366,941
20,273
20,273 $308,000

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.5M
Call Options Held
159K
Put Options Held
229K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $246M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email